Secreted protein acidic and rich in cysteine is a matrix scavenger chaperone

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Chlenski, Alexandre ^a   Guerrero, Lisa J ^a   Salwen, Helen R ^a   Yang, Qiwei ^a,c   Tian, Yufeng ^a   la Madrid, Andres ^a   Mirzoeva, Salida ^b   Bouyer, Patrice G ^a   Xu, David ^a   Walker, Matthew ^a,d   Cohn, Susan L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; COLLAGEN FIBRIL; COLLAGEN TYPE 1; FIBRONECTIN; LAMININ; OSTEONECTIN; VITRONECTIN; CALCIUM; CHAPERONE; COLLAGEN; SCLEROPROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; COLLAGEN METABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROBLAST; IN VITRO STUDY; INTERNALIZATION; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; 129 MOUSE; ANIMAL; CELL CULTURE; CELL STRAIN 3T3; CELL STRAIN HEK293; CYTOLOGY; EXTRACELLULAR SPACE; FEMALE; FLUORESCENCE MICROSCOPY; GENETICS; HUMAN; INTRACELLULAR SPACE; MALE; METABOLISM; MOUSE MUTANT; PROTEIN TRANSPORT;

ANIMALS; CALCIUM; CELLS, CULTURED; COLLAGEN; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; EXTRACELLULAR SPACE; FEMALE; FIBROBLASTS; HEK293 CELLS; HUMANS; INTRACELLULAR SPACE; MALE; MICE; MICE, 129 STRAIN; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; MOLECULAR CHAPERONES; NIH 3T3 CELLS; OSTEONECTIN; PROTEIN TRANSPORT;

EID: 80052829995     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023880     Document Type: Article

References (62)

1. Bradshaw AD, (2009) The role of SPARC in extracellular matrix assembly. J Cell Commun Signal 3: 239-246.
2. Chlenski A, Cohn SL, (2010) Modulation of matrix remodeling by SPARC in neoplastic progression. Semin Cell Dev Biol 21: 55-65.
3. Kaufmann B, Muller S, Hanisch FG, Hartmann U, Paulsson M, et al. (2004) Structural variability of BM-40/SPARC/osteonectin glycosylation: implications for collagen affinity. Glycobiology 14: 609-619.
4. Chlenski A, Liu S, Baker LJ, Yang Q, Tian Y, et al. (2004) Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC. Cancer Res 64: 7420-7425.
5. Sasaki T, Gohring W, Mann K, Maurer P, Hohenester E, et al. (1997) Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens. J Biol Chem 272: 9237-9243.
6. Sage H, Vernon RB, Funk SE, Everitt EA, Angello J, (1989) SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix. J Cell Biol 109: 341-356.
7. Rosenblatt S, Bassuk JA, Alpers CE, Sage EH, Timpl R, et al. (1997) Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: characterization of the binding of vitronectin to osteonectin (BM40, SPARC). Biochem J 324: 311-319.
8. Wang H, Workman G, Chen S, Barker TH, Ratner BD, et al. (2006) Secreted protein acidic and rich in cysteine (SPARC/osteonectin/BM-40) binds to fibrinogen fragments D and E, but not to native fibrinogen. Matrix Biol 25: 20-26.
9. Clezardin P, Malaval L, Morel MC, Guichard J, Lecompte T, et al. (1991) Osteonectin is an alpha-granule component involved with thrombospondin in platelet aggregation. J Bone Miner Res 6: 1059-1070.
10. Clezardin P, Malaval L, Ehrensperger AS, Delmas PD, Dechavanne M, et al. (1988) Complex formation of human thrombospondin with osteonectin. Eur J Biochem 175: 275-284.
11. Kupprion C, Motamed K, Sage EH, (1998) SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J Biol Chem 273: 29635-29640.
12. Raines EW, Lane TF, Iruela-Arispe ML, Ross R, Sage EH, (1992) The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and-BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci U S A 89: 1281-1285.
13. Martinek N, Shahab J, Sodek J, Ringuette M, (2007) Is SPARC an evolutionarily conserved collagen chaperone? J Dent Res 86: 296-305.
14. Neri M, Scalzi-Cancedda F, Cancedda R, (1992) Heat-shock response in cultured chick embryo chondrocytes. Osteonectin is a secreted heat-shock protein. Eur J Biochem 205: 569-574.
15. Kudo H, Hirayoshi K, Kitagawa Y, Imamura S, Nagata K, (1994) Two collagen-binding proteins, osteonectin and HSP47, are coordinately induced in transformed keratinocytes by heat and other stresses. Exp Cell Res 212: 219-224.
16. Emerson RO, Sage EH, Ghosh JG, Clark JI, (2006) Chaperone-like activity revealed in the matricellular protein SPARC. J Cell Biochem 98: 701-705.
17. Giudici C, Raynal N, Wiedemann H, Cabral WA, Marini JC, et al. (2008) Mapping of SPARC/BM-40/osteonectin-binding sites on fibrillar collagens. J Biol Chem 283: 19551-19560.
18. Coxon FP, Taylor A, (2008) Vesicular trafficking in osteoclasts. Semin Cell Dev Biol 19: 424-433.
19. Podgorski I, Linebaugh BE, Koblinski JE, Rudy DL, Herroon MK, et al. (2009) Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis. Am J Pathol 175: 1255-1269.
20. Kzhyshkowska J, Workman G, Cardo-Vila M, Arap W, Pasqualini R, et al. (2006) Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of SPARC. J Immunol 176: 5825-5832.
21. Gooden MD, Vernon RB, Bassuk JA, Sage EH, (1999) Cell cycle-dependent nuclear location of the matricellular protein SPARC: association with the nuclear matrix. J Cell Biochem 74: 152-167.
22. Nie J, Chang B, Traktuev DO, Sun J, March K, et al. (2008) IFATS collection: combinatorial peptides identify alpha5beta1 integrin as a receptor for the matricellular protein SPARC on adipose stromal cells. Stem Cells 26: 2735-2745.
23. Chlenski A, Guerrero LJ, Yang Q, Tian Y, Peddinti R, et al. (2007) SPARC enhances tumor stroma formation and prevents fibroblast activation. Oncogene 26: 4513-4522.
24. Chlenski A, Liu S, Guerrero LJ, Yang Q, Tian Y, et al. (2006) SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix. Int J Cancer 118: 310-316.
25. Gross J, Kirk D, (1958) The heat precipitation of collagen from neutral salt solutions: some rate-regulating factors. J Biol Chem 233: 355-360.
26. Postovit LM, Seftor EA, Seftor RE, Hendrix MJ, (2006) A three-dimensional model to study the epigenetic effects induced by the microenvironment of human embryonic stem cells. Stem Cells 24: 501-505.
27. Chlenski A, Liu S, Crawford SE, Volpert OV, DeVries GH, et al. (2002) SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. Cancer Res 62: 7357-7363.
28. Tyedmers J, Mogk A, Bukau B, (2010) Cellular strategies for controlling protein aggregation. Nat Rev Mol Cell Biol 11: 777-788.
29. Busch E, Hohenester E, Timpl R, Paulsson M, Maurer P, (2000) Calcium affinity, cooperativity, and domain interactions of extracellular EF-hands present in BM-40. J Biol Chem 275: 25508-25515.
30. Bornstein P, (1995) Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol 130: 503-506.
31. Tsang KY, Cheung MC, Chan D, Cheah KS, (2010) The developmental roles of the extracellular matrix: beyond structure to regulation. Cell Tissue Res 339: 93-110.
32. Rozario T, DeSimone DW, (2010) The extracellular matrix in development and morphogenesis: a dynamic view. Dev Biol 341: 126-140.
33. Jarvelainen H, Sainio A, Koulu M, Wight TN, Penttinen R, (2009) Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol Rev 61: 198-223.
34. Egeblad M, Nakasone ES, Werb Z, (2010) Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 18: 884-901.
35. Maurer P, Hohenadl C, Hohenester E, Gohring W, Timpl R, et al. (1995) The C-terminal portion of BM-40 (SPARC/osteonectin) is an autonomously folding and crystallisable domain that binds calcium and collagen IV. J Mol Biol 253: 347-357.
36. Kawasaki K, Weiss KM, (2006) Evolutionary genetics of vertebrate tissue mineralization: the origin and evolution of the secretory calcium-binding phosphoprotein family. J Exp Zool B Mol Dev Evol 306: 295-316.
37. Yan Q, Sage EH, (1999) SPARC, a matricellular glycoprotein with important biological functions. J Histochem Cytochem 47: 1495-1506.
38. Termine JD, Kleinman HK, Whitson SW, Conn KM, McGarvey ML, et al. (1981) Osteonectin, a bone-specific protein linking mineral to collagen. Cell 26: 99-105.
39. Bellahcene A, Castronovo V, (1995) Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am J Pathol 146: 95-100.
40. Hohenester E, Maurer P, Hohenadl C, Timpl R, Jansonius JN, et al. (1996) Structure of a novel extracellular Ca(2+)-binding module in BM-40. Nat Struct Biol 3: 67-73.
41. Christensen KA, Myers JT, Swanson JA, (2002) pH-dependent regulation of lysosomal calcium in macrophages. J Cell Sci 115: 599-607.
42. Gerasimenko JV, Tepikin AV, Petersen OH, Gerasimenko OV, (1998) Calcium uptake via endocytosis with rapid release from acidifying endosomes. Curr Biol 8: 1335-1338.
43. Engel J, Taylor W, Paulsson M, Sage H, Hogan B, (1987) Calcium binding domains and calcium-induced conformational transition of SPARC/BM-40/osteonectin, an extracellular glycoprotein expressed in mineralized and nonmineralized tissues. Biochemistry 26: 6958-6965.
44. Sasaki T, Miosge N, Timpl R, (1999) Immunochemical and tissue analysis of protease generated neoepitopes of BM-40 (osteonectin, SPARC) which are correlated to a higher affinity binding to collagens. Matrix Biol 18: 499-508.
45. Sage H, Johnson C, Bornstein P, (1984) Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture. J Biol Chem 259: 3993-4007.
46. Desai NP, Trieu V, Hwang LY, Wu R, Soon-Shiong P, et al. (2008) Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status. Anticancer Drugs 19: 899-909.
47. Schnitzer JE, Oh P, (1994) Albondin-mediated capillary permeability to albumin. Differential role of receptors in endothelial transcytosis and endocytosis of native and modified albumins. J Biol Chem 269: 6072-6082.
48. Tiruppathi C, Song W, Bergenfeldt M, Sass P, Malik AB, (1997) Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway. J Biol Chem 272: 25968-25975.
49. Goldblum SE, Ding X, Funk SE, Sage EH, (1994) SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function. Proc Natl Acad Sci U S A 91: 3448-3452.
50. Gilmour DT, Lyon GJ, Carlton MB, Sanes JR, Cunningham JM, et al. (1998) Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens. EMBO J 17: 1860-1870.
51. Norose K, Clark JI, Syed NA, Basu A, Heber-Katz E, et al. (1998) SPARC deficiency leads to early-onset cataractogenesis. Invest Ophthalmol Vis Sci 39: 2674-2680.
52. Delany AM, Amling M, Priemel M, Howe C, Baron R, et al. (2000) Osteopenia and decreased bone formation in osteonectin-deficient mice. J Clin Invest 105: 915-923.
53. Bradshaw AD, Puolakkainen P, Dasgupta J, Davidson JM, Wight TN, et al. (2003) SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength. J Invest Dermatol 120: 949-955.
54. Bradshaw AD, Graves DC, Motamed K, Sage EH, (2003) SPARC-null mice exhibit increased adiposity without significant differences in overall body weight. Proc Natl Acad Sci U S A 100: 6045-6050.
55. Bradshaw AD, Reed MJ, Sage EH, (2002) SPARC-null mice exhibit accelerated cutaneous wound closure. J Histochem Cytochem 50: 1-10.
56. Schellings MW, Vanhoutte D, Swinnen M, Cleutjens JP, Debets J, et al. (2009) Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction. J Exp Med 206: 113-123.
57. Mays PK, McAnulty RJ, Campa JS, Laurent GJ, (1991) Age-related changes in collagen synthesis and degradation in rat tissues. Importance of degradation of newly synthesized collagen in regulating collagen production. Biochem J 276: 307-313.
58. Trombetta JM, Bradshaw AD, (2010) SPARC/osteonectin functions to maintain homeostasis of the collagenous extracellular matrix in the periodontal ligament. J Histochem Cytochem 58: 871-879.
59. Bradshaw AD, Baicu CF, Rentz TJ, Van Laer AO, Bonnema DD, et al. (2010) Age-dependent alterations in fibrillar collagen content and myocardial diastolic function: role of SPARC in post-synthetic procollagen processing. Am J Physiol Heart Circ Physiol 298: H614-622.
60. Murphy G, Reynolds JJ, (1985) Current views of collagen degradation. Progress towards understanding the resorption of connective tissues. Bioessays 2: 55-60.
61. Engelholm LH, List K, Netzel-Arnett S, Cukierman E, Mitola DJ, et al. (2003) uPARAP/Endo180 is essential for cellular uptake of collagen and promotes fibroblast collagen adhesion. J Cell Biol 160: 1009-1015.
62. Arora PD, Manolson MF, Downey GP, Sodek J, McCulloch CA, (2000) A novel model system for characterization of phagosomal maturation, acidification, and intracellular collagen degradation in fibroblasts. J Biol Chem 275: 35432-35441.